Ronald Ling
Chief Executive Officer @ ConnectedHealth
Singapore, Singapore
Ronald Ling is a funding round investor at ConnectedHealth in Singapore focused on Mobile and mHealth. Ronald Ling is the Chief Executive Officer at ConnectedHealth Pte Ltd. Ronald Ling attended University of London.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Ronald Ling invests in
Stages Ronald Ling invests in
Countries Ronald Ling invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Mobile 1 (20%)
- mHealth 1 (20%)
- Health Care 1 (20%)
Stage
- Funding Round 1 (20%)
- Convertible Note 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
ConnectedHealth is a digital health company which transforms the management of chronic diseases by:1. Applying technology to clinical data in a way which enables physicians to track patient progress and intervene earlier and more effectively than ever before2. Empowering patients to take charge of their condition through apps which guide andeducate, ongoing monitoring by their physician and personalised health coaching to make behavioural change stickThese innovations will significantly improve clinical outcomes and reduce cost of care by slowing disease progression and preventing complicationsOur flagship product SugoSure, launched in January 2022, is nn innovative, comprehensive and evidence-based system which transforms diabetes careSugoSure's digital health technology supports patients with type 2 diabetes and is delivered in partnership with SugoSure-affiliated doctors.SugoSure subscription also includes personal health coaching, resulting in a uniquely comprehensive approach which enables patients to achieve the best possible long-term outcomes for their diabetes.SugoSure has been developed over 4 years under the leadership of Dr Ronald Ling and sets the company's direction for future growth through innovative, scaleable digital health products which address signifcant unmet needs in chronic disease management. | $363.3K / Dec 31, 2021 | |
|
|
ConnectedHealth is a digital health company which transforms the management of chronic diseases by:1. Applying technology to clinical data in a way which enables physicians to track patient progress and intervene earlier and more effectively than ever before2. Empowering patients to take charge of their condition through apps which guide andeducate, ongoing monitoring by their physician and personalised health coaching to make behavioural change stickThese innovations will significantly improve clinical outcomes and reduce cost of care by slowing disease progression and preventing complicationsOur flagship product SugoSure, launched in January 2022, is nn innovative, comprehensive and evidence-based system which transforms diabetes careSugoSure's digital health technology supports patients with type 2 diabetes and is delivered in partnership with SugoSure-affiliated doctors.SugoSure subscription also includes personal health coaching, resulting in a uniquely comprehensive approach which enables patients to achieve the best possible long-term outcomes for their diabetes.SugoSure has been developed over 4 years under the leadership of Dr Ronald Ling and sets the company's direction for future growth through innovative, scaleable digital health products which address signifcant unmet needs in chronic disease management. | $355.6K / Dec 31, 2020 | |
|
|
ConnectedHealth is a digital health company which transforms the management of chronic diseases by:1. Applying technology to clinical data in a way which enables physicians to track patient progress and intervene earlier and more effectively than ever before2. Empowering patients to take charge of their condition through apps which guide andeducate, ongoing monitoring by their physician and personalised health coaching to make behavioural change stickThese innovations will significantly improve clinical outcomes and reduce cost of care by slowing disease progression and preventing complicationsOur flagship product SugoSure, launched in January 2022, is nn innovative, comprehensive and evidence-based system which transforms diabetes careSugoSure's digital health technology supports patients with type 2 diabetes and is delivered in partnership with SugoSure-affiliated doctors.SugoSure subscription also includes personal health coaching, resulting in a uniquely comprehensive approach which enables patients to achieve the best possible long-term outcomes for their diabetes.SugoSure has been developed over 4 years under the leadership of Dr Ronald Ling and sets the company's direction for future growth through innovative, scaleable digital health products which address signifcant unmet needs in chronic disease management. | $615.4K / Dec 31, 2019 | |
|
|
ConnectedHealth is a digital health company which transforms the management of chronic diseases by:1. Applying technology to clinical data in a way which enables physicians to track patient progress and intervene earlier and more effectively than ever before2. Empowering patients to take charge of their condition through apps which guide andeducate, ongoing monitoring by their physician and personalised health coaching to make behavioural change stickThese innovations will significantly improve clinical outcomes and reduce cost of care by slowing disease progression and preventing complicationsOur flagship product SugoSure, launched in January 2022, is nn innovative, comprehensive and evidence-based system which transforms diabetes careSugoSure's digital health technology supports patients with type 2 diabetes and is delivered in partnership with SugoSure-affiliated doctors.SugoSure subscription also includes personal health coaching, resulting in a uniquely comprehensive approach which enables patients to achieve the best possible long-term outcomes for their diabetes.SugoSure has been developed over 4 years under the leadership of Dr Ronald Ling and sets the company's direction for future growth through innovative, scaleable digital health products which address signifcant unmet needs in chronic disease management. | $326.9K / Convertible Note / Nov 01, 2018 | |
|
|
ConnectedHealth is a digital health company which transforms the management of chronic diseases by:1. Applying technology to clinical data in a way which enables physicians to track patient progress and intervene earlier and more effectively than ever before2. Empowering patients to take charge of their condition through apps which guide andeducate, ongoing monitoring by their physician and personalised health coaching to make behavioural change stickThese innovations will significantly improve clinical outcomes and reduce cost of care by slowing disease progression and preventing complicationsOur flagship product SugoSure, launched in January 2022, is nn innovative, comprehensive and evidence-based system which transforms diabetes careSugoSure's digital health technology supports patients with type 2 diabetes and is delivered in partnership with SugoSure-affiliated doctors.SugoSure subscription also includes personal health coaching, resulting in a uniquely comprehensive approach which enables patients to achieve the best possible long-term outcomes for their diabetes.SugoSure has been developed over 4 years under the leadership of Dr Ronald Ling and sets the company's direction for future growth through innovative, scaleable digital health products which address signifcant unmet needs in chronic disease management. | $361.6K / Jul 06, 2017 |
About ConnectedHealth
ConnectedHealth is a digital health company which transforms the management of chronic diseases by:1. Applying technology to clinical data in a way which enables physicians to track patient progress and intervene earlier and more effectively than ever before2. Empowering patients to take charge of their condition through apps which guide andeducate, ongoing monitoring by their physician and personalised health coaching to make behavioural change stickThese innovations will significantly improve clinical outcomes and reduce cost of care by slowing disease progression and preventing complicationsOur flagship product SugoSure, launched in January 2022, is nn innovative, comprehensive and evidence-based system which transforms diabetes careSugoSure's digital health technology supports patients with type 2 diabetes and is delivered in partnership with SugoSure-affiliated doctors.SugoSure subscription also includes personal health coaching, resulting in a uniquely comprehensive approach which enables patients to achieve the best possible long-term outcomes for their diabetes.SugoSure has been developed over 4 years under the leadership of Dr Ronald Ling and sets the company's direction for future growth through innovative, scaleable digital health products which address signifcant unmet needs in chronic disease management.
ConnectedHealth Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Ronald Ling
Chief Executive Officer
|
|||
|
Rene Schultz
Director, Engineering
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Ronald Ling invest in?
Ronald Ling invests primarily in Mobile, mHealth and Health Care startups, most often at Funding Round and Convertible Note stage. Most of the 5 investments tracked by Shizune back companies in Singapore. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Ronald Ling?
Public channels for Ronald Ling include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Ronald Ling last invest?
The most recent investment recorded for Ronald Ling closed in Dec 2021. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!